PFS Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$5.34M Buy
12,021
+2,888
+32% +$1.33M 0.09% 217
2023
Q1
$4.42M Buy
9,133
+7,964
+681% +$3.79M 0.08% 218
2022
Q4
$600K Buy
1,169
+68
+6% +$34.5K 0.01% 364
2022
Q3
$500K Buy
1,101
+263
+31% +$126K 0.01% 361
2022
Q2
$404K Buy
838
+220
+36% +$109K 0.01% 369
2022
Q1
$304K Buy
+618
New +$282K 0.01% 382

Other funds holding ELV

PFS Investments's ELV Position: Q2 2023 in Review

PFS Investments increased its Elevance Health (ELV) stake by 32% in Q2 2023, buying an estimated $1.33M and bringing the position to 12,021 shares worth $5.34M. The position accounts for 0.09% of the portfolio, ranked #217.

PFS Investments first reported a position in ELV in Q1 2022 and has held it in 6 quarters since. 1,522 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • PFS Investments held 12,021 shares of Elevance Health worth $5.34M as of Q2 2023.
  • PFS Investments bought 2,888 Elevance Health shares in Q2 2023, an estimated $1.33M.
  • Elevance Health made up 0.09% of PFS Investments's portfolio in Q2 2023, its #217 holding.
  • PFS Investments first reported a position in Elevance Health in Q1 2022 and has held it in 6 quarters since.
  • 1,522 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on PFS Investments's 13F filing for Q2 2023, filed 14 Aug 2023.